Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Elicio Therapeutics Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Serina Therapeutics Inc. November 7, 202597.9%
-
Elicio Therapeutics Inc. May 19, 202595.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Serina Therapeutics Inc. | Open-market purchase | +5,000 | $1.77 | $8,850 |
| Jun 11, 2026 | Serina Therapeutics Inc. | Open-market purchase | +5,100 | $1.75 | $8,925 |
| May 22, 2026 | Serina Therapeutics Inc. | Open-market purchase | +10,000 | $1.93 | $19,300 |
| May 21, 2026 | Serina Therapeutics Inc. | Open-market purchase | +10,000 | $1.77 | $17,700 |
Questions about Karen J. Wilson
What boards is Karen J. Wilson on?
Karen J. Wilson sits on the boards of Connect Biopharma Holdings Limited, Elicio Therapeutics Inc. and Serina Therapeutics Inc.
How long has Karen J. Wilson served on boards?
Our records show at least 5 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.